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Abstract 
Quality is conformance to requirement and meeting stated as well as implied 
needs of customer. The word quality is derived from Latin ‘qualis’ means ‘of 
what kind’ and encompasses composition and properties of object. Quality is 
of paramount importance when it is specifically related with drugs. And 
when it comes to herbal drugs, because of several reasons is a herculean task. 
The quality of pharmaceuticals has been a concern of the World Health 
Organization (WHO) since its inception. The setting of global standards is 
requested in Article 2 of the WHO Constitution, which cites as one of the 
Organization’s functions that it should “develop, establish and promote 
international standards with respect to food, biological, pharmaceutical and 
similar products”.  The World Health Assembly - in resolutions WHA31.33 
(1978), WHA40.33 (1987) and WHA42.43 (1989) - has emphasized the need 
to ensure the quality of medicinal plant products by using modern control 
techniques and applying suitable standards. This manual describes a series of 
tests for assessing the quality of medicinal plant materials. The tests are 
designed primarily for use in national drug quality control laboratories in 
developing countries, and complement those described in ‘The international 
pharmacopoeia’ which provides quality specifications only for the few plant 
materials that are included in the WHO ‘Model List of Essential Drugs'. In 
this review, we have addressed some important issues related to quality of 
botanicals and discussed possible application of total quality management for 
herbal drugs. 
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Introduction 
Quality control is an essential operation of the 
pharmaceutical industry. Drugs must be marketed as 
safe and therapeutically active formulations whose 
performance is consistent and predictable. New and 
better medicinal agents are being produced at an 
accelerated rate. At  the  same  time  more exacting and 
 
sophisticated analytical methods are being developed 
for their evaluation [1].  
Before application of newer tools of quality control, it 
is necessary to get insight of herbal drugs. WHO 
defines traditional medicine as including diverse health 
practices, approaches, knowledge and beliefs 
incorporating plant, animal and/or mineral based 
medicines, spiritual therapies, manual techniques and 
exercises applied singularly or in combination to 
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maintain well-being, as well as to treat, diagnose or 
prevent illness. Natural products include various plants, 
animals as well as minerals. Plants serve as most 
valuable source for curing many diseases. Herbal 
medicines include herbal extracts, herbal drug 
preparations and herbal drugs. Herbal drugs are 
unprocessed part of plant or whole plant. Herbs include 
crude plant material such as leaves, flowers, fruit, seed, 
stems, wood, bark, roots, rhizomes or other plant parts, 
which may be entire, fragmented or powdered. Herbal 
preparations include comminuted or powdered 
materials or extracts, tinctures and fatty oils of herbal 
materials, which may be produced by extraction, 
fractionation, purification, concentration or other 
physical or biological processes. Herbal medicines are 
used very commonly in various health practices or 
therapies of Traditional Medicines like Chinese 
medicine, Ayurveda, Unani, Naturopathy, Osteopathy 
and Homeopathy. As herbal wave sweeping over 
society is rising, many of the major pharmaceutical 
companies have renewed their strategies in favor of 
herbal drugs so the time seems to ripe for botanicals of 
better quality [2].  
 
WHO Guidelines for Quality Standardized Herbal 
formulations 
Standardization and quality control parameters for 
herbal formulations are based on following 
fundamental parameters: 
1. Quality control of crude drugs material, plant 
preparations and finished products. 
2. Stability assessment and shelf life. 
3. Safety assessment; documentation of safety 
based on experience or toxicological studies. 
4. Assessment of efficacy by ethnomedical 
information and biological activity evaluations. 
 
Quality Control of Crude Material 
According to pharmaceutical manufacturers association 
of U.S. “quality is the sum of all the factors which 
contribute directly or indirectly to the safety, 
effectiveness and acceptability of the product”[3]. 
Standardization describes all measures taken during 
manufacturing process and quality control leads to 
reproducible quality of particular product. Growing 
need for standardization and quality control of herbal 
medicines is recognized by WHO. In policies and 
checklist on Traditional Medicine(TM) WHO has 
given emphasis on development of national standards 
and technical guidelines and methodology for 
evaluating safety, efficacy and quality of TM. As well 
as WHO also gives stress on development of national 
pharmacopoeia and monographs of medicinal plants, 
cultivation and conservation of medicinal plants to 
ensure their sustainable use are also prime importance 
as botanicals are considered [4]. Standardization of 
botanicals offers many obstacles because synthetic 
drugs have well defined structure and other analytical 
parameters as well as reference standard for 
comparison also established assays and 
pharmacopoeias. Therefore, quality control is not 
problematic for synthetic drug [5]. There are several 
challenges as standardization of herbal product is 
considered like controversial identity of various plants, 
deliberated adulteration of plant material, problems in 
storage and transport, which should be considered [6]. 
One of the impediments in the acceptance of the 
herbal products worldwide is the lack of standard 
quality control profiles. Most of the herbal 
formulations, especially the classical formulations of 
traditional medicine, are polyherbal. Each formulation 
contains 10-20 or more ingredients; a few have even 
50-75 ingredients. Many preparations are either liquid 
or semisolid. For such formulations it is very difficult 
to establish parameters for quality control. Even 
official standards are not available. The unique 
processing methods followed for the manufacture of 
these drugs turn the single drugs into very complex 
mixture, from which separation, identification and 
analysis of the components is a very difficult.  
In Germany, physicians are required to have 
some training in herbal medicine. Considerable 
research on herbal medicine including double-blind, 
placebo-controlled trials are ongoing. Physicians 
recommend and patients use herbal medicines 
extensively. Manufacturers are required to meet 
standards of purity and pharmaceutical activity. 
Commission E, which has had oversight of herbal 
medicines and has determined their safety and efficacy, 
has published 387 monographs (recently translated into 
English by the American Botanical Council). Several 
other European countries also have policies and 
procedures that allow rational oversight of herbal 
medicines [7].  
In the United States, herbs are used either as 
dietary supplements, with minimal standards of safety 
and efficacy, or as drugs, which require expensive and 
cumbersome testing procedures. Middle-of-the-road 
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approach that acknowledges the long history of use of 
many herbal medicines, examines data from many 
sources including other countries, insists on strict 
production standards, and requires absolute safety and 
a classification of efficacy that may vary from 
"unproved" for some conditions to "demonstrated" for 
others. The use of the translated Commission E 
monographs would be very helpful for patients and 
physicians. 
 
Identity of Plant Material 
Authenticity, purity and assay are important aspects of 
the standardization and quality control. As the name 
implies authenticity relates to proving the material is 
true and corresponds to right identity. Quality control 
of botanicals starts right from identification of plant. 
According to WHO general guidelines for 
methodologies on research and evaluation of traditional 
medicines, first step in assuring quality, safety, and 
efficacy of traditional medicines is correct 
identification. As plant can be named in four different 
ways, the common English name, the transliterated 
name, the Latinized pharmaceutical name, the scientific 
name. When binomial names are not used 
misidentification can occur. For example, the scientific 
name of the Chinese herb that is variously transliterated 
as “dong quai”,”dong guai”, and “tang kuei” is 
Angelica polymorpha (formerly sinensis). The common 
English name “Angelica” and Latinized name “Radix 
angelica” could refer either to this species, which is 
used in Australia, or to the Europe species Angelica 
archangelica, depending upon the country of the origin 
[8]. 
Many times two or more different plants have 
same name in Ayurveda. Ayurveda use plants by 
Sanskrit names and there are instances where the same 
name stands for two or three different plants. So, in 
spite of botanical identification, there is still confusion 
with respect to some Ayurvedic drugs. Boerhaavia 
diffusa widely used as ‘quality of life enhancer’ and the 
plant Trianthema portulacastrum both, for instance, are 
known as “Punarva” and both plants may be used at 
same time. Another well-known example is of 
Sankhapushpi, an important medhya drug used for 
improvement of memory power and intellect. 
Shankhapushpi is equated with one or other of the 
following plants depending on the region in India: 
Canscora decussata, Evolvulus alsinoides and Clitoria 
ternataand and sometimes Convulvularis pluricalis. 
There seems to be a lot of confusion in correlating the 
terms Vishnukranti, Shankhapuspi, Aparajita, 
Girikarni etc. to the respective botanical sources. All 
local trade occurs by these vernacular names add to 
confusion. Another problem for Ayurvedic drugs is 
that, there are 56 standard books and different 
manufactures use different reference book, which 
obviously bring about manufacture to manufacture 
variation in same product. 
Misunderstanding problems in procurement of 
authentic plant materials are due to: 
1. Collection of wildly growing plants from 
forests and wastelands. 
2. Traders or suppliers generally have limited 
knowledge of medicinal plants 
3. Folk populace and laborers who are not fully 
aware of the identity of the drugs always do 
collections.  
4. Non homogeneity of plant material due to 
collection from wild sources and different 
geographical locations [9].   
Chemical analysis is so far best method for 
standardization and to detect contamination and for 
plant identification and authentication of medicinal 
plants. Molecular biology techniques can also applied 
to authentication of medicinal plants as complimentary 
techniques [10]. 
 
Variations in Botanicals 
Consistency in composition and biologic activity are 
essential requirements for the safe and effective use of 
therapeutic agents. However, botanical preparations 
rarely meet this standard, as a result of problems in 
identifying plants, genetic variability, variable growing 
conditions, differences in harvesting procedures and 
processing of extracts, and above all, the lack of 
information about active pharmacologic principles 
[11]. Environmental conditions such as sunlight, 
rainfall, altitude, temperature, soil, storage conditions 
as well as different harvesting procedures, time and 
method of collection, manufacturing processes such as 
selecting, drying, purifying, extracting, and genetic 
veriability can create substantial variability in product 
quality and in the concentration of plant chemicals 
within different products. Ecological conditions like 
insect feeding, microbial infections may affect 
secondary metabolites and in turn chemical 
Shinde et al: International Journal of Phytomedicine 1(2009) 4-8 
 
 7
composition of the plant.  Also different parts of same 
plant (example roots, stem and leaves) contain different 
concentration of chemical constituents. At the same 
time diurnal variations (for example paclitaxel, opium 
alkaloids) and seasonal changes also account for 
variability in herbal medicines. The therapeutic or toxic 
components of plant vary depending on the part of the 
plant used as well as stages of ripeness [12]. Products 
from different manufacture vary considerably and it is 
not possible to control all the factors that affect the 
plants chemical composition [13]. Consistency in 
composition and biological activity is essential 
requirement for the safe and effective use of 
therapeutic agent. As botanicals are prone to 
contamination, deterioration there may be batch to 
batch variation in composition. Each herb contains 
large number of diverse compounds and it is not 
possible to analyze for presence or absence for all 
compounds. Modern chromatographic techniques use 
chemical markers, which may not be therapeutically 
active. For many herbs the active constituents are not 
known in this case product may be standardized on 
content of certain marker compounds which are 
chemical characteristic of herb or present in large 
amount. Another well-known example of new active 
marker is St John’s wort. In St John’s wort previously 
it was thought that active constituent is hyperforin but 
later come to know, hypericin has that antidepressant 
activity. So these approaches make assumptions that 
about the relation between the quantity of marker and 
that of the unknown active constituent [14]. 
 
Safety Assessment; Documentation of Safety Based 
on Experience or Toxicological studies 
Adulteration of botanical preparations is another 
important issue. Due to over exploitation of certain 
plants, habitat loss and fragmentation of the forest, 
many medicinal plants have reached to the level of the 
endangered or rare species. These and many other 
factors (like cost of raw material) cause problem for 
availability of genuine drug, which encourages the 
adulteration of plant by substitution with inferior 
commercial varieties, artificially manufactured 
substances, exhausted drugs or cheaper plant or by 
another vegetative part [15]. Several reports suggest 
that many herbal products contain undisclosed 
pharmaceuticals and heavy metals [16]. The intentional 
use of pharmaceutical adulterant is possible. 
Agrochemicals are used to protect the plant from 
infections and insects, which occur as contaminant in 
the crude plant material. More over mechanism of 
action, pharmacokinetics and drug-drug interactions of 
many herbs are still in infancy. At the same time 
growing number of reports about fatal or adverse 
effects of herbal preparations intensifies need for 
national regulation and registration of herbal medicines 
and establishment of safety monitoring. Clinicians 
should not prescribe or recommend herbal remedies 
without well-established efficacy as if they were 
medications that had been proved effective by rigorous 
study. However, these products continue to have great 
appeal to patients, and this reality cannot be ignored. 
Thus, it is imperative to ask patients. This also signifies 
real need for quality control of botanicals [17]. 
Need of quality control and standardization of herbal 
product can be summarized as follows: 
1. When traditional medicines were developed 
technology and concept of standardization was 
quite different. 
2. During past thousand years dynamic process of 
evolution may have changed the identity of 
plant material.  
3. Due to commercialization, supply of genuine 
raw material has become a challenge.  
4. Properties of botanicals may have undergone 
change due to time and environmental factors 
[18].  
These all factors adversely affect quality of crude drug 
and consequently, formulations manufactured by using 
them as ingredient [19]. After this background, it is 
interesting to study how newer quality related tools can 
be applied for herbal drugs.  
The word quality is defined by various ways. It 
is important to understand concept of quality when 
dealing with quality control. According to ISO 9000, 
quality is "Degree to which a set of inherent 
characteristics fulfills requirements". The standard 
defines requirement as need or expectation. Six sigma 
defines it as "Number of defects per million 
opportunities". Philip B. Crosby definition quality is 
"Conformance to requirements". The requirements may 
not fully represent customer expectations; Crosby treats 
this as a separate problem. According to Joseph M. 
Juran, quality means "Fitness for use". Fitness is 
defined by the customer. There are some other 
definitions also. Robert Pirsig: "The result of care". 
Genichi Taguchi, comes with two definition. First one 
is "Uniformity around a target value". The idea is to 
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lower the standard deviation in outcomes, and to keep 
the range of outcomes to a certain number of standard 
deviations, with rare exceptions. Second one is "The 
loss a product imposes on society after it is shipped". 
This definition of quality is based on a more 
comprehensive view of the production system. 
American Society for Quality: "A subjective term for 
which each person has his or her own definition. In 
technical usage, quality can have two meanings: First, 
the characteristics of a product or service that bear on 
its ability to satisfy stated or implied needs and second, 
a product or service free of deficiencies".  
 
Concept of Validation 
In order to control quality of herbal drugs in better 
way, we must amalgamate newer techniques and terms 
to maximum extent. USFDA defines validation as, 
“Validation is documented evidence which provides a 
high degree of assurance that a specific process will 
consistently produce a product meeting its predefined 
specifications and quality attributes”. In early days, 
when the concept of validation came to a 
pharmaceutical industry there was misinterpretation of 
the meaning of validation i.e. validation is nothing but 
wastage of time and money. But over the period of 
time this concept is get changed i.e. validation is not 
wastage of time and money but it is an investment of 
time and money resulting in a production of a quality 
product. 
This concept of validation is getting well 
applied to manufacturing of synthetic drugs from long 
time back. But this concept is not that much deeply or 
methodically studied and applied for the manufacturing 
of herbal drugs. All international regulations like 
USFDA, MCC, MHRA, TGA etc. shows the 
applicability of validation to pharmaceutical 
manufacturing but no one regulation except WHO 
applies the validation concept to manufacturing of 
herbal drugs. WHO also emphasize on very little part 
of validation. Due to that reason the authors want to 
emphasize on the concept of validation and also the 
validation model for manufacturing of herbal drugs. 
There is simple and mostly used validation model for 
manufacturing of synthetic drugs. 
Validation model for synthetic drugs: 
 
 INPUT     →   PROCESS       →   OUTPUT      
We propose how this model is applied to for 
manufacturing of herbal drugs and also the limitation 
of that validation model for synthetic drugs. Generally 
one can describe this model straightforward that means 
starting from input and ends to output. But in case of 
validation one has to go in reverse direction. First of all 
to identify and define which type of quality product 
required i.e. product has its own identity, strength, 
safety, purity and efficacy. This is explained by taking 
one example of herbal tablet or Gutika. 
1. Identity - having specific shape, packing (strip 
or blister or alu-alu) 
2. Strength - having specific strength 
(500mg/tablet, strip of 10 tablets having             
500mg/tablet etc.) 
3. Safety - safe for both i.e. person who is engaged 
in manufacturing and the person who is going 
to take that tablet. 
4. Purity - shows purity (99.9% pure) 
5. Efficacy - it shows the desired therapeutic 
efficacy. 
6. After deciding the required output, the 
processes and its parameter are defined, e.g. for 
manufacturing of tablet (Gutika),  
7. Mixing - how much time is required for 
mixing? 
8. Granulation - which type of granulation (Wet or 
Dry) for how much time? 
9. Compression - how much pressure and for how 
much of time is required? 
10. Packing - which type of packing (strip or blister 
or alu-alu)? 
And lastly that means after defining output and 
process, the inputs are defined. Example: for 
manufacturing of tablet (Gutika), 
1. Personnel 
2. Equipments 
3. Raw material 
4. Packaging material 
5. Environmental conditions – temperature, 
pressure differential, no. of air changes/hr. etc. 
This same model is applicable for herbal drugs but 
there are some limitations such as in case of synthetic 
drugs one can go up to vendor certification (Input) but 
in case of herbal drugs one has to go beyond that i.e. 
not up to vendor certification but up to manufacturers 
certification. The manufacturer certification is difficult 
process but it is possible and this is the need of the  
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today’s herbal industry. One more reason to certify the 
manufacturer is a standardization problem particularly 
the strength of active moiety or drug. 
So that the validation model for manufacturing of 
synthetic drugs is get modified i.e. 
 
Validation Model for Manufacturing of Herbal 
drugs 
There are lots of parameters which has to be considered 
while certifying the manufacturer: 
 
MANUFACTURER CERTIFICATION → INPUT  →   
PROCESS  →   OUTPUT    
 
1. Type of Herbs 
2. Environmental conditions 
3. Time of collection etc. 
4. Variation in composition 
 
Total Quality Management (TQM) rather than 
Quality Control: 
Fig 1: Pareto cause and effect diagram. Let’s look towards difference between TQM and QC. 
Quality control which is generally done at the end of 
operation, mainly control material and product. 
Growing need for quality necessitate the more 
comprehensive technique like Quality Assurance which 
focuses on material, product and process and is on line 
activity. But TQM is more comprehensive which 
covers material, product and all process and starts 
before beginning of operation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2: Ishikawa cause and effect diagram for content variation of herbal drugs. 
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TQM is striving for quality which not only includes 
controlling but also planning, auditing and continuous 
improvement. There are many techniques and tools of 
TQM which can be viewed as key to solve critical 
problem of quality in herbal drugs. To discuss all 
techniques in detail is beyond the scope of this review, 
so we have discussed some of the important techniques 
in brief. 
Pareto, an Italian economist realized that 
approx 90 percent of the wealth in his country was 
owned by 10 percent of the people [20]. According to 
this ‘vital few and trivial many’ concept can be applied 
for herbal drugs. The only vital problem that is control 
of raw material can solve many trivial problems 
associated with quality. At the same time application of 
six sigma can be possible for quality of herbal drugs. 
The inherent variability in herbal drugs cause the 
output varies over a period of time. If this variability is 
considerable, it is impossible to predict the value of a 
characteristic of any single item or at any period of 
time. Any defect in a component, product and service 
could be due to one or more causes. To find out the 
relationship between the cause and effect, a diagram is 
drawn systematically by mapping out all the probable 
causes influencing the effect is called as cause and 
effect diagram or Ishikawa diagram or fishbone 
diagram. The concept of Statistical Quality control 
(SQC) as proposed by Dr. Deming can be used 
effectively to address this issue. Demings PDCA (Plan, 
Do, Check and Act) cycle not only maintain quality but 
also improves when cycle goes on running [21]. 
Following are some examples of cause and effect 
diagram: This basic cause and effect diagram can be 
applied to detect the problems associated with herbal 
drugs for better quality control in following manner 
(Figure 1, 2) 
 
Conclusion 
 
Because of gravity of the problem, profound 
knowledge of the important herbs found in India and 
widely used in Ayurvedic formulation along with new 
standardization techniques is of utmost importance. 
Incorporation of this will authenticate quality thereby 
reducing further problems. Quality is inspected at right 
starting point then it will eliminate all bottlenecks in 
quality control of herbal formulations to obtain better 
formulations. We wish to draw the attention of readers 
to the rapidly evolving standardization aspects of 
herbal drugs with some new ideas, so that this area 
could be expanded significantly. More emphasis should 
be given on total quality management (TQM) for better 
quality of herbal drugs. Then one can dream a utopian 
situation where quality is built in the product so deeply, 
that there should be no need to control. 
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